Has Chirag Barbhaiya, MD received payments from drug or device companies?

Yes. Drug and device makers reported $155,510 in general payments to Chirag Barbhaiya, MD across 367 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Chirag Barbhaiya, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Chirag Barbhaiya, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Chirag Barbhaiya, MD

Clinical Cardiac Electrophysiology · New York, NYNPI 1134386782

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $106,135 of the $155,510 with a category attached, or 68.2%. Abbott accounts for 70.7% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2024 at $60,435 and has fallen 67.3% since, to $19,784 in 2025. Among clinical cardiac electrophysiology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$155,510in general payments, 2019–2025

Across 367 payments — averaging $423.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$110K
Biosense Webster, Inc.$17K
Biotronik Inc.$9K
Medtronic$6K
Medical Device Business Services, Inc.$5K
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$4K
plus $4K from 18 others

$51,089in research payments, 2019–2025

Across 87 payments — averaging $587.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Biotronik Inc.$24K
Abbott$21K
Impulse Dynamics (USA) Inc.$5K

What the payments were for

Consulting fees$106,13568%
Speaking & faculty fees$14,6889%
Grants$1,9161%
Travel & lodging$21,33314%
Food & beverage$11,3627%
Education$760%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	147	$109,966
Biosense Webster, Inc.	40	$16,989
Biotronik Inc.	46	$8,817
Medtronic(2 entities)	75	$6,192
Medical Device Business Services, Inc.	3	$5,400
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	4	$4,000
Philips North America LLC	2	$2,021
Boston Scientific	13	$605
Preventice Services, LLC	1	$500
Impulse Dynamics (USA) Inc.	4	$252
Kestra Medical Technology Services, Inc.	4	$151
Cardiva Medical, Inc.	3	$77
Novartis	4	$77
Bardy Diagnostics, Inc.	4	$74
Atricure, Inc.	2	$65
Altathera Pharmaceuticals LLC	2	$60
Kiniksa Pharmaceuticals International, PLC	2	$48
Sanofi-aventis U.S. LLC	2	$46
Johnson & Johnson	3	$45
Pfizer	2	$38
Tactile Systems Technology Inc	1	$26
Baxter Healthcare	1	$25
Irhythm Technologies, Inc.	1	$23
Esperion Therapeutics, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Epic$25,473
Carto 3$20,500
TACTICATH ABLATION CATHETER, SENSOR ENABLED$18,538
ENSITE$17,133
EnSite Precision Cardiac Mapping System$12,300
ENSITE PRECISION$10,835
ASSURITY$6,050
TactiCath Quartz CFA Catheter$4,984
LifeVest$4,000
Therapy Ablation Catheter$3,752
AVEIR$2,700
QUARTET$2,625
HeartMate$2,250
Edora$2,025
IGT D Peripheral$2,000
EVERA MRI XT DR SURESCAN$569
TENDRIL$525
BG Mini Plus$500
Micra$391
FLEXABILITY$337

How this compares

$155,510 in reported general payments places this provider in the 90th percentile of 214 clinical cardiac electrophysiology providers in New York.

See all clinical cardiac electrophysiology providers in New York →

Medicare billing

Part B allowed, 2024

$543,698

Medicare patients

2,285

Services billed

5,654

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Metoprolol Succinate	15	$323

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in New York

Vivek ReddyNew York$14.9M
Jacob KoruthNew York$3.7M
Srinivas DukkipatiNew York$2.7M
Amir AhmadiNew York$789K
Larry ChinitzNew York$448K
James IpNew York$347K
Nicholas SkipitarisNew York$293K
Mohit TuragamNew York$202K
David LauNew York$202K
Christopher LiuNew York$181K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →